PHARMACOGENETICS: GENETIC BASIS OF DRUG RESPONSE

Authors

  • Murodov Muhammadrizo Muhsin ugli Qo‘qon University, Andijan Branch

DOI:

https://doi.org/10.55640/

Keywords:

Pharmacogenetics, Drug response, Genetic variations, Personalized medicine, Gene-drug interaction

Abstract

Pharmacogenetics is a branch of science that studies how genetic variations influence an individual’s response to drugs. Differences in genes can affect the absorption, metabolism, distribution, and excretion of medications, leading to variations in efficacy and the risk of adverse effects. Understanding these genetic factors enables healthcare professionals to predict patient-specific drug responses and optimize therapy. The development of personalized medicine relies on pharmacogenetic insights to improve treatment outcomes, minimize side effects, and enhance patient safety. As research advances, pharmacogenetics plays a crucial role in tailoring drug therapy according to genetic profiles, thus transforming conventional approaches to medication management.

Downloads

Download data is not yet available.

References

1.IngelmanSundberg, M. “Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.” Trends in Pharmacological Sciences, 2004.

2.Evans, W. E., & McLeod, H. L. “Pharmacogenomics — drug disposition, drug targets, and side effects.” New England Journal of Medicine, 2003.

3.Crews, K. R., Hicks, J. K., Pui, C.-H., Relling, M. V., & Evans, W. E. “Pharmacogenomics and individualized medicine: translating science into practice.” Clinical Pharmacology & Therapeutics, 2012.

4.A Review of the Important Role of CYP2D6 in Pharmacogenomics. PubMed+1

5.The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions. MDPI

6.Pharmacogenetics of Second Generation Antihistamines: A Systematic Review. @WalshMedical

7.Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes. BioMed Central

8.Voriconazole Therapy and CYP2C19 Genotype — NCBI Bookshelf. НЦБИ

9.Impact of Pharmacogenomics in Clinical Practice. MDPI

10.Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: Metaanalysis. JAMA Network

11.Application and Utility of Pharmacogenetics in the Clinical Laboratory. avensonline.org

12.Review: Rare CYP2C19 and CYP2D6 Variants in Pharmacogenetics. Frontiers

13.Pharmacogenetics: (a historic review) — Um.edu.mt publication. L-Università ta' Malta

14.Frontiers in Psychiatry – Genetic Variation and DrugMetabolizing Enzymes Review. Frontiers

15.Pharmacogenetics of CYP- (CYP2D6, CYP2C19) — CME presentation by ARUP (University of Utah).

Downloads

Published

2025-11-17

Issue

Vol. 4 No. 10 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

PHARMACOGENETICS: GENETIC BASIS OF DRUG RESPONSE. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(10), 1259-1261. https://doi.org/10.55640/

Similar Articles

1-10 of 762

You may also start an advanced similarity search for this article.